Studies show similar efficacy, but patient preference often leans towards the injectable form
If fewer than four days (96 hours) have passed since the scheduled injection day, patients should administer the missed dose as soon as they remember
Therefore, intracellular glutamine level is not high
Retatrutide is the potential new champion of efficacy, offering a distinct advantage in specific metabolic comorbidities, particularly liver health, due to its GIP GLP-1 Glucagon agonist structure
Liraglutide (a daily injection) produced a more modest average weight loss of about 4% to 5% , according to 24 trials (9,937 participants), but still increased the proportion of people who achieved clinically meaningful weight loss compared with placebo
Possible mechanisms behind the semaglutide-NAION connection include: Rapid weight loss leading to changes in intracranial pressure Alterations in blood flow to the optic nerve Metabolic changes affecting optic nerve function Its important to note that current research has limitations